This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (80)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Micheline Maccario, MD

Arch Neurol. 1968;19(5):525-534.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE RAPIDLY accumulating literature on nonketotic hyperglycemia attests to increased interest in this entity.^1-48 The metabolic abnormalities that define the syn drome have been delineated (Table 1). The necessity for its early recognition and prompt treatment with large quantities of hypotonic fluids and insulin is well established. In contrast, the extent to which neurological dysfunction can result from this metabolic imbalance is not commonly recognized. The fact that some of these patients can present with overt, focal neurological signs⁴⁴ is denied^21,40 or minimized.³⁵ Some interpret their early appearance as evidence that "strokes" are an etiological factor in the development of nonketotic hyperglycemia.^7,48 To others the appearance of focal neurological deficit in the course of the illness signifies the occurrence of "strokes" and such a possibility is listed as a cause of death.³⁶ Finally, these patients are often simply misdiagnosed as cerebrovascular accidents presenting . . . [Full Text PDF of this Article]

Author Affiliations
Brooklyn, NY

From the Division of Neurology, Department of Medicine, The Brooklyn-Cumberland Medical Center, Brooklyn, NY. Dr. Maccario is currently with Bellevue Hospital, New York University.

Footnotes
Submitted for publication May 11, 1968; accepted May 28.

Reprint requests to 550 First Ave, New York 10016.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?